NEXPOINT ASSET MANAGEMENT L.P. 13D/13G Filings for Paratek Pharmaceuticals, Inc. (PRTK)

NEXPOINT ASSET MANAGEMENT L.P. 13D and 13G filings for Paratek Pharmaceuticals, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2021-02-12
4:47 pm
Purchase
2020-12-31 13G Paratek Pharmaceuticals, Inc.
PRTK
NEXPOINT ASSET MANAGEMENT L.P. 2,301,555
5.000%
2,301,555increase
(New Position)
Filing